Brown Advisory’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.61M | Sell |
29,471
-1,914
| -6% | -$624K | 0.01% | 413 |
|
|
2025
Q1 | $8.47M | Sell |
31,385
-2,495
| -7% | -$674K | 0.01% | 423 |
|
|
2024
Q4 | $7.97M | Sell |
33,880
-5,243
| -13% | -$1.23M | 0.01% | 455 |
|
|
2024
Q3 | $10.8M | Sell |
39,123
-3,234
| -8% | -$889K | 0.01% | 413 |
|
|
2024
Q2 | $10.3M | Sell |
42,357
-3,129
| -7% | -$760K | 0.01% | 410 |
|
|
2024
Q1 | $6.8M | Buy |
45,486
+6,757
| +17% | +$1.01M | 0.01% | 458 |
|
|
2023
Q4 | $7.41M | Buy |
38,729
+3,517
| +10% | +$673K | 0.01% | 441 |
|
|
2023
Q3 | $6.24M | Sell |
35,212
-376
| -1% | -$66.6K | 0.01% | 444 |
|
|
2023
Q2 | $6.76M | Buy |
35,588
+4,290
| +14% | +$815K | 0.01% | 439 |
|
|
2023
Q1 | $6.27M | Sell |
31,298
-517
| -2% | -$104K | 0.01% | 448 |
|
|
2022
Q4 | $7.56M | Sell |
31,815
-1,327
| -4% | -$315K | 0.01% | 421 |
|
|
2022
Q3 | $6.63M | Sell |
33,142
-2,105
| -6% | -$421K | 0.01% | 418 |
|
|
2022
Q2 | $5.14M | Sell |
35,247
-7,361
| -17% | -$1.07M | 0.01% | 455 |
|
|
2022
Q1 | $6.96M | Buy |
42,608
+16,030
| +60% | +$2.62M | 0.01% | 435 |
|
|
2021
Q4 | $4.51M | Buy |
+26,578
| New | +$4.51M | 0.01% | 492 |
|